Literature DB >> 26740235

Next-generation sequencing discloses a nonsense mutation in the dystrophin gene from long preserved dried umbilical cord and low-level somatic mosaicism in the proband mother.

Mariko Taniguchi-Ikeda1,2, Yasuhiro Takeshima3, Tomoko Lee3, Masahiro Nishiyama1,2, Hiroyuki Awano1, Mariko Yagi4, Ai Unzaki1, Kandai Nozu1, Hisahide Nishio1, Masafumi Matsuo5, Hiroki Kurahashi6, Tatsushi Toda2,7, Ichiro Morioka1, Kazumoto Iijima1.   

Abstract

Duchene muscular dystrophy (DMD) is a progressive muscle wasting disease, caused by mutations in the dystrophin (DMD) on the X chromosome. One-third of patients are estimated to have de novo mutations. To provide in-depth genetic counseling, the comprehensive identification of mutations is mandatory. However, many DMD patients did not undergo genetic diagnosis because detailed genetic diagnosis was not available or their mutational types were difficult to identify. Here we report the genetic testing of a sporadic DMD boy, who died >20 years previously. Dried umbilical cord preserved for 38 years was the only available source of genomic DNA. Although the genomic DNA was severely degraded, multiplex ligation-dependent probe amplification analysis was performed but no gross mutations found. Sanger sequencing was attempted but not conclusive. Next-generation sequencing (NGS) was performed by controlling the tagmentation during library preparation. A nonsense mutation in DMD (p.Arg2095*) was clearly identified in the proband. Consequently, the identical mutation was detected as an 11% mosaic mutation from his healthy mother. Finally, the proband's sister was diagnosed as a non-carrier of the mutation. Thus using NGS we have identified a pathogenic DMD mutation from degraded DNA and low-level somatic mosaicism, which would have been overlooked using Sanger sequencing.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26740235     DOI: 10.1038/jhg.2015.157

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  18 in total

1.  Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

Authors:  E Bakker; H Veenema; J T Den Dunnen; C van Broeckhoven; P M Grootscholten; E J Bonten; G J van Ommen; P L Pearson
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

2.  Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.

Authors:  Matthew D Shirley; Hao Tang; Carol J Gallione; Joseph D Baugher; Laurence P Frelin; Bernard Cohen; Paula E North; Douglas A Marchuk; Anne M Comi; Jonathan Pevsner
Journal:  N Engl J Med       Date:  2013-05-08       Impact factor: 91.245

Review 3.  A rising titan: TTN review and mutation update.

Authors:  Claire Chauveau; John Rowell; Ana Ferreiro
Journal:  Hum Mutat       Date:  2014-07-21       Impact factor: 4.878

4.  Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center.

Authors:  Yasuhiro Takeshima; Mariko Yagi; Yo Okizuka; Hiroyuki Awano; Zhujun Zhang; Yumiko Yamauchi; Hisahide Nishio; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2010-05-20       Impact factor: 3.172

5.  Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD).

Authors:  E Kondo-Iida; K Kobayashi; M Watanabe; J Sasaki; T Kumagai; H Koide; K Saito; M Osawa; Y Nakamura; T Toda
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

6.  MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls.

Authors:  B Janssen; C Hartmann; V Scholz; A Jauch; J Zschocke
Journal:  Neurogenetics       Date:  2005-01-18       Impact factor: 2.660

7.  Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA).

Authors:  Valentina Gatta; Oronzo Scarciolla; Anna Rita Gaspari; Chiara Palka; Maria Vittoria De Angelis; Antonio Di Muzio; Paolo Guanciali-Franchi; Giuseppe Calabrese; Antonino Uncini; Liborio Stuppia
Journal:  Hum Genet       Date:  2005-04-20       Impact factor: 4.132

8.  Deletion and duplication screening in the DMD gene using MLPA.

Authors:  Tanja Lalic; Rolf H A M Vossen; Jordy Coffa; Jan P Schouten; Marija Guc-Scekic; Danijela Radivojevic; Marina Djurisic; Martÿn H Breuning; Stefan J White; Johan T den Dunnen
Journal:  Eur J Hum Genet       Date:  2005-11       Impact factor: 4.246

Review 9.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

10.  Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy.

Authors:  A T J M Helderman-van den Enden; R de Jong; J T den Dunnen; J J Houwing-Duistermaat; A L J Kneppers; H B Ginjaar; M H Breuning; E Bakker
Journal:  Clin Genet       Date:  2009-05       Impact factor: 4.438

View more
  5 in total

1.  A resolved discrepancy between multiplex PCR and multiplex ligation-dependent probe amplification by targeted next-generation sequencing discloses a novel partial exonic deletion in the Duchenne muscular dystrophy gene.

Authors:  Chang Liu; Huiting Deng; Cheng Yang; Xixi Li; Yanrong Zhu; Xiangfa Chen; Hui Li; Shuo Li; Hao Cui; Xiaoyan Zhang; Xiaoyue Tan; Dong Li; Zhujun Zhang
Journal:  J Clin Lab Anal       Date:  2018-05-25       Impact factor: 2.352

2.  Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.

Authors:  Emma Tabe Eko Niba; Atsushi Nishida; Van Khanh Tran; Dung Chi Vu; Masaaki Matsumoto; Hiroyuki Awano; Tomoko Lee; Yasuhiro Takeshima; Hisahide Nishio; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2017-01-19       Impact factor: 3.172

3.  Genetic Analysis of UGT1A1 Polymorphisms Using Preserved Dried Umbilical Cord for Assessing the Potential of Neonatal Jaundice as a Risk Factor for Autism Spectrum Disorder in Children.

Authors:  Tomoko Horinouchi; Kaori Maeyama; Masashi Nagai; Masami Mizobuchi; Yasuko Takagi; Yuka Okada; Takeshi Kato; Mio Nishimura; Yoko Kawasaki; Mieko Yoshioka; Satoshi Takada; Hisayuki Matsumoto; Yuji Nakamachi; Jun Saegusa; Sachiyo Fukushima; Kazumichi Fujioka; Kazumi Tomioka; Hiroaki Nagase; Kandai Nozu; Kazumoto Iijima; Noriyuki Nishimura
Journal:  J Autism Dev Disord       Date:  2021-03-17

4.  EMQN best practice guidelines for genetic testing in dystrophinopathies.

Authors:  Carl Fratter; Raymond Dalgleish; Stephanie K Allen; Rosário Santos; Stephen Abbs; Sylvie Tuffery-Giraud; Alessandra Ferlini
Journal:  Eur J Hum Genet       Date:  2020-05-18       Impact factor: 4.246

5.  Targeted next-generation sequencing-based molecular diagnosis of congenital hand malformations in Chinese population.

Authors:  Litao Qin; Guiyu Lou; Liangjie Guo; Yuwei Zhang; Hongdan Wang; Li Wang; Qiaofang Hou; Hongyan Liu; Xichuan Li; Shixiu Liao
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.